Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 108.00
Bid: 108.00
Ask: 109.00
Change: -1.50 (-1.37%)
Spread: 1.00 (0.926%)
Open: 109.50
High: 110.00
Low: 108.00
Prev. Close: 109.50
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

October 2020 Trading Update

18 Nov 2020 07:00

RNS Number : 6410F
International Personal Finance Plc
18 November 2020
 

18 November 2020

International Personal Finance plc

October 2020 Trading Update

 

International Personal Finance plc (IPF) specialises in providing unsecured consumer credit to around 1.7 million customers across 10 markets. We operate the world's largest home credit business and a leading fintech business, IPF Digital.

 

As part of our ongoing strategy to regularly inform and update investors on key operational performance metrics during the Covid-19 pandemic, IPF is publishing the following information for October 2020.

 

· Highlights

Ø Continued improvements in trading performance

Ø Collections effectiveness increased 2 ppts to 97% of pre-Covid expectations

Ø Further increase in credit issued to 60% of pre-Covid expectations

Ø Net cashflow of £7 million reflecting the progressive shift towards growth

Ø Successful bond exchange and refinancing of the Group

 

Gerard Ryan, CEO at IPF, commented: "I'm very pleased to report a further improvement in our collections performance and that we are carefully increasing lending to our highest quality customers. We are well-prepared for operating during the second wave of the Covid pandemic, with our priority being the health and safety of our colleagues and customers. Successfully completing the refinancing of the business provides the financial foundation on which we will continue to provide credit responsibly to under-served consumers and deliver long-term growth and value to all our stakeholders."

 

· Continued improvements in trading performance

We continued to deliver progressive improvements in our operational performance in October with a further increase in credit issued and a good collections performance. The second wave of the pandemic has resulted in rising Covid cases in all our European markets. Various restrictions have been introduced by governments, but our agents continue to serve their customers effectively. Whilst freedom of movement restrictions are beginning to result in a slight reduction in demand, the expected negative impact on collections for which we had planned has not arisen. In Mexico, reported Covid cases are stable and various state-by-state restrictions remain in place. Safeguarding our people and customers remains our priority and, applying the lessons learned in the first wave of the pandemic, we are well-prepared, providing safety guidance and PPE for all of our field-based colleagues and agents, and alternative repayment options for affected customers.

 

· Strong collections effectiveness

We continued to deliver a strong level of collections effectiveness, rising to 97% of pre-Covid expectations in October. All of our businesses (excluding Hungary where an opt-out moratorium is in place) delivered a good performance. As reported in our Q3 2020 statement, we continue to expect a modest reduction in collections effectiveness during the winter period, notwithstanding the fact we have seen improvements in the month of October. 

 

· Good credit issued

The robust collections effectiveness delivered since the half year has enabled a progressive relaxation of credit settings in order to increase lending and reduce the rate of contraction of our receivables portfolio. This strategy has driven an increase in credit issued to 60% of pre-Covid expectations, primarily in our home credit operations in Europe and Mexico. Our plan remains to continue increasing credit issued during the remainder of the year while maintaining a clear focus on portfolio quality and the macroeconomic effects of Covid.

 

· Net cashflow generation

Net cashflow generation in October was £7 million. This more modest level of cash generation compared to recent months was expected and reflects our strategic decision to increase lending cautiously to rebuild the portfolio, together with tax payments falling due in a number of our jurisdictions in the month.

 

· Successful refinancing of the business

As previously reported, a new 5-year bond issue and amended covenant package across all the Group's bonds has been successfully completed. This, together with the Group's bank facilities, totals £560 million of funding with amended covenants that is available to support future growth of the business. This compares to borrowings net of non-operational cash balances of £401 million at the end of October.

 

 

Investor relations and media contact:

International Personal Finance

Rachel Moran

+44 (0)7760 167637 / +44 (0)113 285 6798

 

A copy of this statement can be found on our website - www.ipfin.co.uk

 

 

Legal Entity Identifier: 213800II1O44IRKUZB59

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDDLFFBFLXFBD
Date   Source Headline
2nd May 20241:53 pmRNSResults of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Update
1st May 20246:01 pmRNSBoard Committee Membership Changes
1st May 20246:00 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
8th Apr 20241:13 pmRNSDirector/PDMR Shareholding
5th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 202410:48 amRNSDirector/PDMR Shareholding
3rd Apr 20243:29 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20245:09 pmRNSDirector/PDMR Shareholding
25th Mar 20244:44 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20245:09 pmRNSDirector/PDMR Shareholding
19th Mar 20243:56 pmRNSDirector/PDMR Shareholding
18th Mar 20244:11 pmRNSDirector/PDMR Shareholding
15th Mar 202410:38 amRNSFinal Dividend Timetable Correction
14th Mar 20247:00 amRNSFinal Results and Accounts
26th Feb 20247:00 amRNSDelay of year-end results announcement
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Dec 20239:08 amRNSHolding(s) in Company
14th Dec 202311:24 amRNSPublication of Final Terms
24th Nov 20237:02 amRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSFinal Confirmation & Results of Exchange Offer
17th Nov 20233:18 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSAppointment of Joint Broker
14th Nov 20233:09 pmRNSHolding(s) in Company
8th Nov 20237:00 amRNSNotice of Investor Webinar - 7 December 2023
3rd Nov 20234:14 pmRNSIssuance and amendment to Final Terms
2nd Nov 20231:29 pmRNSCash Offer Launch
2nd Nov 20231:18 pmRNSExchange Offer
2nd Nov 20231:16 pmRNSPublication of a Prospectus
26th Oct 20237:01 amRNSRoadshow Announcement
26th Oct 20237:00 amRNSQ3 2023 Trading Update
25th Oct 20232:12 pmRNSChange of Senior Independent Director
24th Oct 20233:19 pmRNSPublication of Final Terms - Replacement Notice
24th Oct 20237:00 amRNSPublication of Final Terms
20th Oct 20237:00 amRNSUpdate on Annual General Meeting 2023 Vote
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20231:46 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
24th Aug 20234:35 pmRNSPublication of a Prospectus
1st Aug 20237:00 amRNSHalf-year Report
13th Jul 202311:14 amRNSHolding(s) in Company
3rd Jul 20232:30 pmRNSTotal Voting Rights
3rd Jul 20239:20 amRNSBlock listing Interim Review
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20234:48 pmRNSDirector/PDMR Shareholding
4th May 202311:17 amRNSDirector/PDMR Shareholding
2nd May 202312:28 pmRNSTotal Voting Rights
27th Apr 20234:27 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.